PET/CT details hint at survival of head/neck cancer patients
April 15, 2014 -- Japanese researchers have found that several PET/CT parameters -- in particular, a ring-shaped area of FDG uptake -- are reliable predictors of survival for patients with head and neck squamous cell carcinoma. Results of their study were published in the April issue of the American Journal of Roentgenology.
LED Dental signs SE distributors for VELscope
April 15, 2014 -- LED Dental has entered into a nonexclusive partnership with Atlanta Dental Supply Company and Nashville Dental for distribution of its VELscope Vx enhanced oral assessment system and product line within the Southeastern U.S. market.
Study: 4 proteins may lead to improved HNC treatment
April 11, 2014 -- A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against head and neck squamous cell cancers that are resistant to treatment, according to a study presented at this week's American Association for Cancer Research meeting.
Seattle Mariners, DenMat offer players VELscope screenings
April 9, 2014 -- April is Oral Cancer Awareness Month, and the Seattle Mariners and DenMat in partnership with LED Medical Diagnostics have teamed up to offer the players and staff VELscope Vx oral cancer screenings during spring training.
Prognosis of HPV-positive tumors in HNC varies
April 8, 2014 -- Patients with throat cancer who are positive for the human papillomavirus (HPV) have a good prognosis, but until now the effect of being HPV-positive on the prognosis of other head and neck cancers (HNC) was unknown.
Gene changes may be responsible for recurrent HNC
April 7, 2014 -- Gene alterations may be responsible for recurrent head and neck cancer (HNC) in some patients, and an existing cancer drug may be an effective treatment, according to research presented at this week's American Association for Cancer Research annual meeting.
New biomarker linked to better outcomes of HNC
April 2, 2014 -- Researchers have identified a new biomarker linked to better outcomes in patients with head and neck cancer (HNC) and non-small cell lung cancer, according to a new study in Cancer.
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer.